Prof. Anne Marie Healy, Professor of Pharmaceutics and Pharmaceutical Technology in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin (TCD) and Co-Principal Investigator in SSPC’s Medicines theme, has been awarded SSPC Investigator of the Year 2019. This award recognises the accomplishments Anne Marie has contributed to the Centre with exceptional scientific and leadership outputs.
Prof. Healy received a B.Sc. in Pharmacy and a Ph.D. in Pharmaceutics, both from the University of Dublin. She joined the School of Pharmacy, TCD in 1992 as a Lecturer in Pharmaceutics. In 2010 she was elected Fellow of Trinity College. She was awarded a Special Visiting Research Fellowship by CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil) in 2014 to further her collaborative research with the Faculty of Pharmacy of the Federal University of Rio de Janeiro. This research focuses on single and combination dosage forms and on the re-formulation of “old” drugs to improve treatment by either the pulmonary or oral route.
She has over 25 years’ experience in pharmaceutics, pharmaceutical technology and drug delivery research. Her research is focused on obtaining an increased understanding of the physicochemical properties of active and excipient materials used in a variety of different dosage forms, and on harnessing that knowledge to improve product design in terms of in vitro and subsequently in vivo performance. This research objective is achieved through collaborative efforts and interdisciplinary research with both academic and industry partners.
Prof. Healy’s specific research interests include pharmaceutical material science, preformulation and formulation of pharmaceuticals, amorphous solids, cocrystals, formulating poorly soluble drugs, pharmaceutical processing, and pulmonary drug delivery.
Recently, Prof. Healy won funding under the EPSRC-SFI Centres for Doctoral Training (CDT) Partnership programme. The funding, secured from SFI, enables engagement with two of the world leading Schools of Pharmacy in the UK, at the University of Nottingham and University College London, in a new CDT in Transformative Pharmaceutical Technologies, which has a particular focus on formulation science and advanced drug delivery.
Prof. Healy has published extensively, and has graduated 21 PhD students and mentored 25 postdoctoral researchers.